서브메뉴
검색
Assessing T-Cell Cross-Reactivity to Sars-CoV-2 Variants- [electronic resource]
Assessing T-Cell Cross-Reactivity to Sars-CoV-2 Variants- [electronic resource]
- 자료유형
- 학위논문
- Control Number
- 0016933735
- International Standard Book Number
- 9798380262941
- Dewey Decimal Classification Number
- 600
- Main Entry-Personal Name
- Ravi, Subeksha Govinda Rajan.
- Publication, Distribution, etc. (Imprint
- [S.l.] : University of Pittsburgh., 2023
- Publication, Distribution, etc. (Imprint
- Ann Arbor : ProQuest Dissertations & Theses, 2023
- Physical Description
- 1 online resource(43 p.)
- General Note
- Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
- General Note
- Advisor: Mailliard, Robbie;Marques, Ernesto T.;Rinaldo, Charles R.
- Dissertation Note
- Thesis (M.Sc.)--University of Pittsburgh, 2023.
- Restrictions on Access Note
- This item must not be sold to any third party vendors.
- Summary, Etc.
- 요약The coronavirus pandemic is a major, ongoing public health crisis. COVID-19 has resulted in over 6 million deaths as of April 2023 according to WHO. The COVID-19 mRNA vaccine widely administered in the United States was based on the spike protein of the Washington strain of SARS-CoV-2. Several new studies have indicated that a phenomenon like original antigenic sin (where prior exposure to an antigen leads to an ineffective immune response against related antigens) might be occurring in COVID. In this study, we wanted to determine if a COVID-19 mRNA vaccine-induced memory CTLs cross-react with Delta/Omicron variant epitopes without target cell killing. To test this, we identified HLA-A2 restricted, CD8+ T-cell epitopes in the spike protein that differ between the Washington strain Vs the Delta and/or Omicron variants. We collected T-cells from HLA-A2 positive, MWCCS donors who were vaccinated but not naturally exposed to any variant of SARS-CoV-2 and expanded the antigen-specific T-cells ex-vivo. We then assessed the cross-reactive potential of these Washington variant spike-specific CD8+ T-cells (readout was optimized to detect CD8+ T-cells) against the variant peptides generated using IFNgamma ELISpot assay. We tested 14 peptide pairs and found that vaccine-induced CD8+ T-cells can cross-react with epitope variants. We also observed a decreased T-cell reactivity to the variant epitopes compared to the Washington epitopes in some cases and an increased T-cell reactivity to the variant epitopes compared to the Washington epitopes in some other cases. Another interesting observation was that MHC binding affinity and T-cell binding affinity did not always correlate with the T-cell responses (IFN-g production) observed. Our future efforts will be aimed at testing the killing capacity of the CTLs when exposed to variant-antigen expressing target cells. The findings from this study has laid a groundwork in determining the efficacy of the COVID vaccine and to determine if there is need for the development of a more efficacious COVID vaccine.
- Subject Added Entry-Topical Term
- Infections.
- Subject Added Entry-Topical Term
- Monoclonal antibodies.
- Subject Added Entry-Topical Term
- Human immunodeficiency virus--HIV.
- Subject Added Entry-Topical Term
- COVID-19 vaccines.
- Subject Added Entry-Topical Term
- mRNA vaccines.
- Subject Added Entry-Topical Term
- Dendritic cells.
- Subject Added Entry-Topical Term
- Memory.
- Subject Added Entry-Topical Term
- Severe acute respiratory syndrome coronavirus 2.
- Subject Added Entry-Topical Term
- Cytotoxicity.
- Subject Added Entry-Topical Term
- Health care.
- Subject Added Entry-Topical Term
- Mutation.
- Subject Added Entry-Topical Term
- Cloning.
- Subject Added Entry-Topical Term
- Cytokines.
- Subject Added Entry-Topical Term
- Cohort analysis.
- Subject Added Entry-Topical Term
- Public health.
- Subject Added Entry-Topical Term
- Amino acids.
- Subject Added Entry-Topical Term
- Antigens.
- Subject Added Entry-Topical Term
- Pathophysiology.
- Subject Added Entry-Topical Term
- Drug dosages.
- Subject Added Entry-Topical Term
- Disease transmission.
- Subject Added Entry-Topical Term
- Cellular biology.
- Subject Added Entry-Topical Term
- Immunology.
- Subject Added Entry-Topical Term
- Pathology.
- Subject Added Entry-Topical Term
- Physiology.
- Added Entry-Corporate Name
- University of Pittsburgh.
- Host Item Entry
- Dissertations Abstracts International. 85-03B.
- Host Item Entry
- Dissertation Abstract International
- Electronic Location and Access
- 로그인을 한후 보실 수 있는 자료입니다.
- Control Number
- joongbu:641331